MSH|^~\&|MD_NBS_Staging^2.16.840.1.114222.4.3.3.54.2^ISO|MD^2.16.840.1.114222.4.1.10058^ISO|PHINCDS^2.16.840.1.114222.4.3.2.10^ISO|PHIN^2.16.840.1.114222^ISO|20170928110205.830||ORU^R01^ORU_R01|NOT12423001MD012017-09-28T11:02:05.830|P|2.5.1|||||||||NND_ORU_v2.0^PHINProfileID^2.16.840.1.114222.4.10.3^ISO~Arbo_Case_Map_v1.0^PHINMsgMapID^2.16.840.1.114222.4.10.4^ISOPID|1||PSN15212002MD01^^^MD_NBS_Staging&2.16.840.1.114222.4.3.3.54.2&ISO||~^^^^^^S||19880318|M||2106-3^White^2.16.840.1.113883.6.238|^^^24^20607^^^^24033|||||||||||2186-5^Not Hispanic or Latino^2.16.840.1.113883.6.238OBR|1|""|CAS12447001MD01^MD_NBS_Staging^2.16.840.1.114222.4.3.3.54.2^ISO|PERSUBJ^Person Subject^2.16.840.1.114222.4.5.274|||20170920081257.000|||||||||||||||20170928110059.947|||C||||||11705^Dengue, severe^2.16.840.1.114222.4.5.277OBR|2|""|CAS12447001MD01^MD_NBS_Staging^2.16.840.1.114222.4.3.3.54.2^ISO|NOTF^Individual Case Notification^2.16.840.1.114222.4.5.274|||20170920081257.000|||||||||||||||20170928110059.947|||C||||||11705^Dengue, severe^2.16.840.1.114222.4.5.277OBX|1|CWE|271807003^Rash^2.16.840.1.113883.6.96^271807003^Rash^L||Y^Yes^2.16.840.1.113883.12.136||||||FOBX|2|CWE|3723001^Arthritis^2.16.840.1.113883.6.96^3723001^Arthritis^L||Y^Yes^2.16.840.1.113883.12.136||||||FOBX|3|CWE|386661006^Fever^2.16.840.1.113883.6.96^386661006^Fever^L||Y^Yes^2.16.840.1.113883.12.136||||||FOBX|4|CWE|40440-0^Serotype^2.16.840.1.113883.6.1^404400^Dengue (DENV) Serotype^L||36700002^Dengue virus, type 4^2.16.840.1.113883.6.96||||||FOBX|5|CWE|419188005^Leukopenia^2.16.840.1.113883.6.96^419188005^Leukopenia^L||Y^Yes^2.16.840.1.113883.12.136||||||FOBX|6|CWE|42106004^Tourniquet Test Positive^2.16.840.1.113883.6.96^42106004^Tourniquet Test Positive^L||Y^Yes^2.16.840.1.113883.12.136||||||FOBX|7|CWE|44695005^Paralysis or Paresis^2.16.840.1.113883.6.96^44695005^Paralysis or Paresis^L||Y^Yes^2.16.840.1.113883.12.136||||||FOBX|8|ST|56831-1^Other Symptoms (Specify)^2.16.840.1.113883.6.1^568311^Other Symptoms^L||Patient had severe bleeding symptoms leading to shock and death||||||FOBX|9|CWE|68962001^Myalgia^2.16.840.1.113883.6.96^68962001^Myalgia^L||Y^Yes^2.16.840.1.113883.12.136||||||FOBX|10|CWE|80515008^Liver Enlargement (Hepatomegaly)^2.16.840.1.113883.6.96^80515008^Liver Enlargement (Hepatomegaly)^L||Y^Yes^2.16.840.1.113883.12.136||||||FOBX|11|CWE|91454002^Cerebrospinal Fluid Pleocytosis^2.16.840.1.113883.6.96^91454002^Cerebrospinal Fluid (CSF) Pleocytosis (>=5 WBC)^L||Y^Yes^2.16.840.1.113883.12.136||||||FOBX|12|CWE|ARB001^Arbovirus^2.16.840.1.114222.4.5.232^ARB001^Type of Arbovirus^L||34348001^Dengue virus (organism)^2.16.840.1.113883.6.96||||||FOBX|13|CWE|ARB002^ClinicalSyndrome^2.16.840.1.114222.4.5.232^ARB002^Clinical Syndrome^L||PHC1458^Severe Dengue^2.16.840.1.114222.4.5.274||||||FOBX|14|CWE|ARB003^LabAcquired^2.16.840.1.114222.4.5.232^ARB003^Occupationally lab acquired^L||N^No^2.16.840.1.113883.12.136||||||FOBX|15|CWE|ARB005^BloodDonor^2.16.840.1.114222.4.5.232^ARB005^Blood Donor^L||N^No^2.16.840.1.113883.12.136||||||FOBX|16|CWE|ARB006^BloodTransfusion^2.16.840.1.114222.4.5.232^ARB006^Blood Transfusion Received^L||N^No^2.16.840.1.113883.12.136||||||FOBX|17|CWE|ARB007^OrganDonor^2.16.840.1.114222.4.5.232^ARB007^Organ Donor^L||N^No^2.16.840.1.113883.12.136||||||FOBX|18|CWE|ARB008^OrganTransplant^2.16.840.1.114222.4.5.232^ARB008^Organ Transplant Received^L||N^No^2.16.840.1.113883.12.136||||||FOBX|19|CWE|ARB009^BreastFedInfant^2.16.840.1.114222.4.5.232^ARB009^Breast Fed Infant^L||N^No^2.16.840.1.113883.12.136||||||FOBX|20|CWE|ARB011^Published^2.16.840.1.114222.4.5.232^ARB011^CDC Publish Indicator^L||Y^Yes^2.16.840.1.113883.12.136||||||FOBX|21|CWE|ARB013^IdentifiedByBloodDonorScreening^2.16.840.1.114222.4.5.232^ARB013^Identified By Blood Donor Screening^L||N^No^2.16.840.1.113883.12.136||||||FOBX|22|CWE|ARB050^Clinical Syndrome, Secondary^2.16.840.1.114222.4.5.232^ARB050^Clinical Syndrome, Secondary^L||698293005^Acute flaccid paralysis^2.16.840.1.113883.6.96||||||FOBX|23|CWE|DEM126^Country of Birth^2.16.840.1.114222.4.5.232^DEM126^Country of Birth^L||PRI^PUERTO RICO^1.0.3166.1||||||FOBX|24|CWE|INV107^Reporting Jurisdiction^2.16.840.1.114222.4.5.232^INV107^Jurisdiction^L||^^^240033^Prince Georges, MD^L||||||FOBX|25|CWE|INV109^Case Investigation Status Code^2.16.840.1.114222.4.5.232^INV109^Investigation Status^L||385651009^In progress (qualifier value)^2.16.840.1.113883.6.96||||||FOBX|26|CWE|INV128^Hospitalized^2.16.840.1.114222.4.5.232^INV128^Was the patient hospitalized for this illness?^L||Y^Yes^2.16.840.1.113883.12.136||||||FOBX|27|TS|INV132^Admission Date^2.16.840.1.114222.4.5.232^INV132^Admission Date^L||20170715000000.000||||||FOBX|28|TS|INV133^Discharge Date^2.16.840.1.114222.4.5.232^INV133^Discharge Date^L||20170723000000.000||||||FOBX|29|SN|INV134^Duration of hospital stay in days^2.16.840.1.114222.4.5.232^INV134^Total duration of stay in the hospital (in days)^L||^8||||||FOBX|30|TS|INV137^Date of Illness Onset^2.16.840.1.114222.4.5.232^INV137^Illness Onset Date^L||20170630000000.000||||||FOBX|31|TS|INV138^Illness End Date^2.16.840.1.114222.4.5.232^INV138^Illness End Date^L||20170725000000.000||||||FOBX|32|SN|INV139^Illness Duration^2.16.840.1.114222.4.5.232^INV139^Illness Duration^L||^25|d^day^2.16.840.1.113883.6.8|||||FOBX|33|CWE|INV145^Did the patient die from this illness^2.16.840.1.114222.4.5.232^INV145^Did the patient die from this illness?^L||Y^Yes^2.16.840.1.113883.12.136||||||FOBX|34|TS|INV146^Date of Death^2.16.840.1.114222.4.5.232^INV146^Date of Death^L||20170725000000.000||||||FOBX|35|TS|INV147^Investigation Start Date^2.16.840.1.114222.4.5.232^INV147^Investigation Start Date^L||20170829000000.000||||||FOBX|36|CWE|INV152^Case Disease Imported Code^2.16.840.1.114222.4.5.232^INV152^Where was the disease acquired?^L||C1512888^International^2.16.840.1.113883.6.86||||||FOBX|37|CWE|INV153^Imported Country (Country of Origin)^2.16.840.1.114222.4.5.232^INV153^Imported Country^L||PRI^PUERTO RICO^1.0.3166.1||||||FOBX|38|CWE|INV163^Case Class Status Code^2.16.840.1.114222.4.5.232^INV163^Case Status^L||410605003^Confirmed present (qualifier value)^2.16.840.1.113883.6.96||||||FOBX|39|SN|INV165^MMWR Week^2.16.840.1.114222.4.5.232^INV165^MMWR Week^L||^26||||||FOBX|40|TS|INV166^MMWR Year^2.16.840.1.114222.4.5.232^INV166^MMWR Year^L||2017||||||FOBX|41|SN|INV2001^Patient Age Reported^2.16.840.1.114222.4.5.232^INV2001^Reported Age^L||^29|a^year^2.16.840.1.113883.6.8|||||FOBX|42|CWE|INV501^Country of Usual Residence^2.16.840.1.114222.4.5.232^INV501^Country of Usual Residence^L||USA^UNITED STATES^1.0.3166.1||||||FOBX|43|CWE|LAB617^Serum Paired Antibody Test Interpretation^2.16.840.1.114222.4.5.232^LAB617^Serum Paired Antibody Test Interpretation^L||PHC1446^Greater than or equal to 4 fold rise^2.16.840.1.114222.4.5.274||||||FOBX|44|CWE|NOT109^Reporting State^2.16.840.1.114222.4.5.232^NOT109^Reporting State^L||24^Maryland^2.16.840.1.113883.6.92||||||FOBX|45|CWE|NOT116^National Reporting Jurisdiction^2.16.840.1.114222.4.5.232^NOT116^National Reporting Jurisdiction^L||24^Maryland^2.16.840.1.113883.6.92||||||FOBX|46|CWE|PHC1400^Retro-orbital Pain^2.16.840.1.114222.4.5.274^PHC1400^Retro-orbital Pain^L||Y^Yes^2.16.840.1.113883.12.136||||||FOBX|47|CWE|PHC1401^Extravascular Fluid Accumulation^2.16.840.1.114222.4.5.274^PHC1401^Extravascular Fluid Accumulation^L||Y^Yes^2.16.840.1.113883.12.136||||||FOBX|48|CWE|PHC1402^Mucosal Bleeding^2.16.840.1.114222.4.5.274^PHC1402^Mucosal Bleeding^L||Y^Yes^2.16.840.1.113883.12.136||||||FOBX|49|CWE|PHC1403^Severe Plasma Leakage^2.16.840.1.114222.4.5.274^PHC1403^Severe Plasma Leakage^L||Y^Yes^2.16.840.1.113883.12.136||||||FOBX|50|CWE|PHC1404^Severe Bleeding^2.16.840.1.114222.4.5.274^PHC1404^Severe Bleeding^L||Y^Yes^2.16.840.1.113883.12.136||||||FOBX|51|CWE|PHC1405^Severe Organ Involvement^2.16.840.1.114222.4.5.274^PHC1405^Severe Organ Involvement^L||Y^Yes^2.16.840.1.113883.12.136||||||FOBX|52|CWE|PHC1456^Increasing Hematocrit and Decreased Platelet^2.16.840.1.114222.4.5.274^PHC1456^Increasing Hematocrit and Decreased Platelet^L||Y^Yes^2.16.840.1.113883.12.136||||||FOBX|53|TS|33882-2^Specimen Collection Date^2.16.840.1.113883.6.1^338822^Specimen Collection Date^L|1|20170716000000.000||||||FOBX|54|CWE|66746-9^Specimen Type^2.16.840.1.113883.6.1^667469^Specimen Type^L|1|258450006^Cerebrospinal fluid sample^2.16.840.1.113883.6.96||||||FOBX|55|CWE|INV290^Test Type^2.16.840.1.114222.4.5.232^INV290^Test Type^L|1|LAB612^Arbovirus CSF PRNT^2.16.840.1.114222.4.5.232||||||FOBX|56|CWE|INV291^Test Result / Interpretation^2.16.840.1.114222.4.5.232^INV291^Test Result/Interpretation^L|1|10828004^Positive^2.16.840.1.113883.6.96||||||FOBX|57|CWE|LAB606^Performing Lab Type^2.16.840.1.114222.4.5.232^LAB606^Performing Lab Type^L|1|PHC412^CDC laboratory^2.16.840.1.114222.4.5.274||||||FOBX|58|TS|33882-2^Specimen Collection Date^2.16.840.1.113883.6.1^338822^Specimen Collection Date^L|2|20170716000000.000||||||FOBX|59|CWE|66746-9^Specimen Type^2.16.840.1.113883.6.1^667469^Specimen Type^L|2|119297000^Blood specimen^2.16.840.1.113883.6.96||||||FOBX|60|CWE|INV290^Test Type^2.16.840.1.114222.4.5.232^INV290^Test Type^L|2|LAB610^Arbovirus Serum PCR^2.16.840.1.114222.4.5.232||||||FOBX|61|CWE|INV291^Test Result / Interpretation^2.16.840.1.114222.4.5.232^INV291^Test Result/Interpretation^L|2|10828004^Positive^2.16.840.1.113883.6.96||||||FOBX|62|CWE|LAB606^Performing Lab Type^2.16.840.1.114222.4.5.232^LAB606^Performing Lab Type^L|2|PHC414^State laboratory^2.16.840.1.114222.4.5.274||||||FOBX|63|TS|33882-2^Specimen Collection Date^2.16.840.1.113883.6.1^338822^Specimen Collection Date^L|3|20170715000000.000||||||FOBX|64|CWE|66746-9^Specimen Type^2.16.840.1.113883.6.1^667469^Specimen Type^L|3|119364003^Serum specimen^2.16.840.1.113883.6.96||||||FOBX|65|CWE|INV290^Test Type^2.16.840.1.114222.4.5.232^INV290^Test Type^L|3|LAB624^Arbovirus Serum IgM^2.16.840.1.114222.4.5.232||||||FOBX|66|CWE|INV291^Test Result / Interpretation^2.16.840.1.114222.4.5.232^INV291^Test Result/Interpretation^L|3|10828004^Positive^2.16.840.1.113883.6.96||||||FOBX|67|CWE|LAB606^Performing Lab Type^2.16.840.1.114222.4.5.232^LAB606^Performing Lab Type^L|3|PHC645^Commercial laboratory^2.16.840.1.114222.4.5.274||||||FOBX|68|TS|33882-2^Specimen Collection Date^2.16.840.1.113883.6.1^338822^Specimen Collection Date^L|4|20170716000000.000||||||FOBX|69|CWE|66746-9^Specimen Type^2.16.840.1.113883.6.1^667469^Specimen Type^L|4|258450006^Cerebrospinal fluid sample^2.16.840.1.113883.6.96||||||FOBX|70|CWE|INV290^Test Type^2.16.840.1.114222.4.5.232^INV290^Test Type^L|4|LAB611^Arbovirus CSF IgM^2.16.840.1.114222.4.5.232||||||FOBX|71|CWE|INV291^Test Result / Interpretation^2.16.840.1.114222.4.5.232^INV291^Test Result/Interpretation^L|4|10828004^Positive^2.16.840.1.113883.6.96||||||FOBX|72|CWE|LAB606^Performing Lab Type^2.16.840.1.114222.4.5.232^LAB606^Performing Lab Type^L|4|PHC414^State laboratory^2.16.840.1.114222.4.5.274||||||FOBX|73|TS|33882-2^Specimen Collection Date^2.16.840.1.113883.6.1^338822^Specimen Collection Date^L|5|20170716000000.000||||||FOBX|74|CWE|66746-9^Specimen Type^2.16.840.1.113883.6.1^667469^Specimen Type^L|5|119364003^Serum specimen^2.16.840.1.113883.6.96||||||FOBX|75|CWE|INV290^Test Type^2.16.840.1.114222.4.5.232^INV290^Test Type^L|5|LAB625^Arbovirus Serum PRNT^2.16.840.1.114222.4.5.232||||||FOBX|76|CWE|INV291^Test Result / Interpretation^2.16.840.1.114222.4.5.232^INV291^Test Result/Interpretation^L|5|10828004^Positive^2.16.840.1.113883.6.96||||||FOBX|77|CWE|LAB606^Performing Lab Type^2.16.840.1.114222.4.5.232^LAB606^Performing Lab Type^L|5|PHC412^CDC laboratory^2.16.840.1.114222.4.5.274||||||FOBX|78|CWE|INV290^Test Type^2.16.840.1.114222.4.5.232^INV290^Test Type^L|6|LAB613^Arbovirus CSF PCR^2.16.840.1.114222.4.5.232||||||FOBX|79|CWE|INV291^Test Result / Interpretation^2.16.840.1.114222.4.5.232^INV291^Test Result/Interpretation^L|6|373121007^Test Not Done^2.16.840.1.113883.6.96||||||FOBX|80|ST|INV173^State Case ID^2.16.840.1.114222.4.5.232^INV173^State Case ID^L||CAS12447001MD01||||||F 